SCHEMBL18842482

SCHEMBL18842482

CC(C)(C)C(C(=O)Oc1ccc(O)cc1)C(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ELANE P08246 9/20 0.51
▸ ATM Q13315 1/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.46
▸ MAPK1 P28482 2/20 0.42
▸ MEN1 O00255 2/20 0.42
▸ KMT2A Q03164 2/20 0.42
▸ KDM4E B2RXH2 1/20 0.42
▸ CA12 O43570 3/20 0.40
▸ CA1 P00915 3/20 0.40
▸ CA2 P00918 3/20 0.40
▸ CA7 P43166 3/20 0.40
▸ CA9 Q16790 3/20 0.40
▸ CA14 Q9ULX7 3/20 0.40
▸ ESR1 P03372 2/20 0.40
▸ ESR2 Q92731 1/20 0.40
▸ LMNA P02545 2/20 0.40
▸ MAPT P10636 1/20 0.40
▸ ADRB2 P07550 1/20 0.40
▸ ADRB1 P08588 1/20 0.40
▸ ADRB3 P13945 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24850059 0.82 L3MBTL1 (0.66) ELANEATML3MBTL1MEN1KMT2A
SCHEMBL10618820 0.80 ATM (0.68) ELANEATML3MBTL1MEN1KMT2A
SCHEMBL3678450 0.78 ELANE (0.48) ELANEATML3MBTL1MEN1KMT2A
SCHEMBL5186261 0.78 ELANE (0.68) ELANEMEN1KMT2AKDM4ECA12
SCHEMBL14647613 0.78 ELANE (0.46) ELANEATML3MBTL1MEN1KMT2A
SCHEMBL12999209 0.78 ELANE (0.45) ELANEATML3MBTL1MAPK1MEN1
SCHEMBL20345279 0.76 ELANE (0.44) ELANEATML3MBTL1MAPK1MEN1
SCHEMBL28184139 0.76 ELANE (0.50) ELANEMEN1KMT2AKDM4ECA12
SCHEMBL28183245 0.76 ELANE (0.50) ELANEMEN1KMT2AKDM4ECA12
SCHEMBL624333 0.76 ELANE (0.50) ELANEMEN1KMT2AKDM4ECA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170174801-A1 NON-CHEMICAL AMPLIFICATION TYPE RESIST COMPOSITION, NON-CHEMICAL AMPLIFICATION TYPE RESIST FILM, PATTERN FORMING METHOD, AND METHOD FOR MANUFACTURING ELECTRONIC DEVICE FUJIFILM CORPORATION (JP) 2017-06-22 — — US disclosed
US-20170131632-A1 ACID DIFFUSION CONTROL AGENT, RADIATION-SENSITIVE RESIN COMPOSITION, RESIST PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD JSR CORPORATION (JP) 2017-05-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170131632-A1 ACID DIFFUSION CONTROL AGENT, RADIATION-SENSITIVE RESIN COMPOSITION, RESIST PATTERN-FORMING METHOD, COMPOUND, AND PRODUCTION METHOD RER1, RFC4, RFC2 ELANE 2309/4885ATM 3150/4885L3MBTL1 1425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback